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ABSTRACT 
Objective: The primary objective of this study was to investigate the hypoglycaemic activity of S. caryophyllatum in alloxan induced diabetic mice.  
Methods: Alloxan was administered as a single dose (60mg/kg, b. wt) to induce diabetes. Methanol extracts from S. caryophyllatum (250mg/kg body 
weight/day) was administered for 14 days to alloxan induced diabetic mice and the body weight changes and fasting blood sugar levels were 
monitored on 0, 7th and 14th day. Glycosylated haemoglobin levels also estimated. 
 Result: The results suggest that the administration of S. caryophyllatum have hypoglycaemic activity in alloxan induced diabetic mice and their 
effect was equivalent to that of reference drug Glibenclamide. Conclusions: Methanol extract of S. caryophyllatum possesses anti-diabetic effect on 
Alloxan induced diabetic mice due to the presence of secondary metabolites. 
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INTRODUCTION 
Diabetes Mellitus is a universal metabolic disorder, with an 
increasing global trend and of particular concern to India; it has 
significant impact on the health, quality of life and life expectancy of 
patients as well as healthcare expenditure. The prevalence of 
diabetes is about 366 million people worldwide and it is likely to 
increase to 552 million and more by the year 2030 and its 
occurrence was found to be high in India, China, and USA (Whiting et 
al., 2011). India now has the world’s largest diabetic population, 
encompassing an estimated 35 million people out of an overall 
population of 1 billion. In just over 13 years (i.e. 2025) the country 
will have almost 200 million people (approximately 15% of the 
population) affected by diabetes (Geetanjali et al., 2010). With 
increasing incidence and mortality from diabetic complications, 
prompt and adequate glycaemic control is paramount if the 
management can meaningfully improve the quality of life and 
increase life expectancy.  
The World Health Organization (WHO) has also recommended the 
evaluation of traditional plant treatments for diabetes, as they are 
effective, non-toxic, with less or no side effects and is considered to 
be an excellent candidate for oral therapy (Shokeen et al., 2008).  
Many valuable sources of knowledge are available in different 
cultures dealing with medication for various diseases and disorders 
from ancient time particularly for diabetes. Many of these 
recommendations make use of natural herbs with no side effects to 
the individuals. Since the information is too old, there arises a need 
to revive these recommendations carefully by making use of modern 
scientific techniques. These recommendations may lead to the 
development of "alternative systems" of medicine. Very few plants 
have been so far studied further, in depth, for investigating their site 
and mechanism of action for possible development of anti-diabetic 
drugs. Plants like Allium cepa (Onion, piyaj), Allium sativum (garlic, 
lasun), Syzygium cumini (Syn. Eugenia jambolana; Momordica 
charantia (bitter gourd; karela) Gymema sylvestre (Gurmar), 
Pterocarpus marsupium etc. have attracted more attention to the 
scientists as well as laymen in the field of antidiabetic activity in 
recent years (Sheela et al., 1995; Sitasawad et al., 2000 and Soni et 
al., 2011). 
 Many species of Myrtaceae family has been widely used to treat 
diabetes by the traditional practioners over many centuries 
(Nadkarni, 1954). Among them, root, leaf, bark, fruit and seed 
extract of S. cumini have shown very good antihyperglycemic activity  
 
by many workers (Shrotri et al., 1963; Bansal et al., 1981; Achrekar 
et al., 1991; Grover et al., 2000; Sharma et al., 2003). On the other 
hand, one could expect that the antihyperglycemic activity may also 
be present among the very close related species of Myrtaceae family 
such as S. caryophyllatum. Syzygium caryophyllatum is one of the 
species that has been categorized as endangered tree species under 
the international nature for conservation of nature (IUCN) red list of 
threatened species. It is known as Wild black plum. In Tamil it is 
known as Kattu naval. It was used in the folklore medicine for 
various ailements, but there are only very few report available 
regarding the antihyperglycemic activity. Hence, the present 
investigation was aimed to prove the antihyperglycemic activity of 
leaf extract of S. caryophyllatum on alloxan induced diabetic animal 
model. 
MATERIALS AND METHODS 
Collection of the plant material 
Syzygium caryophyllatum (L.) Alston (Myrtaceae) is collected during 
the month of October 2009 from Palani Hills, Tamil Nadu, India. It is 
identified and authenticated by Dr. S. Padmavathy, Associate 
Professor, Department of Botany, Nirmala College for Women 
(Autonomous), Coimbatore, Tamil Nadu and also the voucher 
specimen (T1) was deposited. 
Preparation of the extract 
Freshly collected sample of S. caryophyllatum leaves, were washed 
2-3 times with water followed by distilled water and shade dried. All 
the dried parts were pulverized by mechanical grinder (Willy mill) 
to get the powder through 100-mess sieve and then stored in a 
refrigerator. The shade dried powdered plant material (250g) was 
extracted with methanol using a soxhlet apparatus. Then the extract 
was concentrated in a rotary evaporator. 
Animals 
Three months old Swiss albino mice (24-25g) were obtained from 
the animal- breeding center of Kerala Agricultural University, 
Trissur, Kerala. All animals were kept in an environmentally 
controlled room with a 12h light/12h dark cycle. All the experiments 
were performed according to ethical guidelines for the investigation 
of experimental pain in conscious animals (659/02/a/CPCSEA).  
 Vol 6, Suppl 4, 2013                                                                                                                                                                                                              ISSN - 0974-2441                                                                                                                                                                                                 
C. SAVITHA RABEQUE1*, S. PADMAVATHY2  
Rabeque et al. 
Asian J Pharm Clin Res, Vol 6, Suppl 4, 2013, 203-205  
204 
 
Induction of diabetes 
The mice were injected alloxan dissolved in sterile normal saline at a 
dose of 60mg/kg body weight, intraperitoneally. After a fortnight, 
mice with marked hyperglycaemia were selected and used for the 
study 
Experimental design 
The animals were randomly divided into four groups with 5 rats in 
each group and treated as follows 
Group I: Normal control (Saline) (by using an intragastric catheter 
tube (IGC). 
Group II: Diabetic control 
Group III: Diabetic rats received Glibenclamide (2mg/kg b.wt.) for 
14 days. for 14 days by 
IGC 
Group IV: Diabetic rats received S. caryophyllatum Methanol extract 
(250 mg/kg b.wt) for 14 days by IGC. 
The change in body weight and fasting plasma glucose (FPG) levels 
of all the rats were recorded at regular intervals during the 
experimental period. No sign of toxicity was noticed on the 
behaviour and general health of the animals when exposed to the 
extract. Animals described as fasted were deprived of food for at 
least 12 h but allowed free access to drinking water. Blood samples 
were drawn at the end of study. Blood glucose estimation (Sasaki et 
al., 1972) and glycosylated haemoglobin (Kynoch and Lehmann, 
1977) were done on 14th day of the study. 
RESULT 
Body weight 
Diabetes is characterized by weight loss and it was also seen in this 
study. Normal control animals were found to be stable in their body 
weight but diabetic mice showed statistically significant reduction in 
body weight on day 7 and 14. Alloxan caused body weight reduction, 
which was reversed by the treatment with methanol extracts of S. 
caryophyllatum after 7 and 14 days of treatment. However, the 
treatment with S. caryophyllatum weight increase is low when 
compared to the glibenclamide treated groups (Table -1). 
Table 1: Effect of methanol leaf extract of S. caryophyllatum leaf 
extracts on body weight changes in normal and alloxan induced 
diabetic mice 
Treatment Day 0(g) Day 7(g) Day 14(g) 
   Group -  I 24.40 ± 0.26 25.38 ± 0.5    25.12 ± 0.26 
   Group -  II 24.72 ± 0.27 19.56 ± 0.19** 18.62± 0.12** 
   Group -  III 24.64 ± 0.02 25.55 ± 0.21a 26.69 ± 0.22aa 
   Group -  IV 24.66 ± 0.23 25.20 ± 0.12a 26.06 ± 0.21aa 
Each Value is SEM ± 5 individual observations * P < 0.05; ** 
P<0.01;*** P<0.001 Compared normal control vs -Diabetic mice.  
a -P < 0.05; aa - P<0.01 Compared -Diabetic mice vs drug treated 
Group I: Mice received normal saline were served as a normal control. (By 
using an intragastric catheter tube (IGC). 
Group II: Diabetic mice received normal saline 14 days by IGC and 
served as diabetic control. 
Group III: Diabetic mice received glibenclamide at the dose of 2mg/ 
Kg body weight, daily, orally for 14 days by IGC. 
Group IV: Diabetic mice received S. caryophyllatum extract at the 
dose of 250 mg/kg b.wt for 14 days by IGC. 
Changes in serum glucose concentration 
The daily administration of S. caryophyllatum extract (250 mg/kg) 
on alloxan induced diabetic mice caused a significant reduction in 
blood glucose level when compared with the vehicle-treated 
(P<0.05) group and day zero value (P<0.05). Similarly, repeated 
administration of glibenclamide (2mg/kg) twice a day for 7 and 14 
days caused a significant reduction (P<0.01) in the blood glucose 
level in alloxan induced diabetic mice when compared to vehicle and 
day zero values. S. caryophyllatum treated group have shown good 
hypoglycaemic activity (Table-2). 
Table 2: Effect of methanol leaf extract of S. caryophyllatum on 
fasting plasma glucose level in normal and alloxan induced 
diabetic mice 
Treatment Day 0(g) Day 7(g) Day 14(g) 
   Group -  I 104.30 ± 10.99 109.20 ± 10.47 110.56 ± 9.84 
   Group -  II 220.34 ± 8.19 267.15 ± 11.15
*
 292.40 ± 10.16
*
 
   Group -  III 216.40 ± 3.97 165.40 ± 17.57 106.00 ±9.49
**
 
   Group -  IV  223.26 ± 3.26 174.40 ± 18.13
* 
 112.16 ± 9.26
*
 
Each Value is SEM ± 5 individual observations * P < 0.05; ** 
P<0.01;*** P<0.001 Compared normal control vs -Diabetic mice.  
a -P < 0.05; aa - P<0.01 Compared -Diabetic mice vs drug treated 
Group I: Mice received normal saline were served as a normal control. (By 
using an intragastric catheter tube (IGC). 
Group II: Diabetic mice received normal saline 14 days by IGC and 
served as diabetic control. 
Group III: Diabetic mice received glibenclamide at the dose of 2mg/ 
Kg body weight, daily, orally for 14 days by IGC. 
Group IV: Diabetic mice received S. caryophyllatum extract at the 
dose of 250 mg/kg b.wt for 14 days by IGC. 
Gycosylated haemoglobin 
Glycosylated haemoglobin levels were significantly increased in 
diabetic group when compared with normal group of animals. 
Administration of S. caryophyllatum extract and glibenclamide to 
diabetic mice significantly reversed all the changes to near normal 
levels. As expected, the Hb A1 C level of S. caryophyllatum extract and 
glibenclamide treated groups has shown significant reduction when 
compared to the diabetic untreated groups. This effect was bringing 
down to normal in S. caryophyllatum extract and standard drug 
treated groups (Table-3). 
Table 3: Effect of methanol leaf extract of S. caryophyllatum on 
Glycosylated haemoglobin level in normal and alloxan induced 
diabetic mice 
Treatment Hb A1c              (%) 
Group -  I 3.43±0.23 
Group -  II 9.78±0.34** 
Group -  III 3.89±0.11 aa 
Group -  IV 3.97±0.15 aa  
Each Value is SEM ± 5 individual observations * P < 0.05; ** 
P<0.01;*** P<0.001 Compared normal control vs -Diabetic mice.  
a -P < 0.05; aa - P<0.01 Compared -Diabetic mice vs drug treated 
Group I: Mice received normal saline were served as a normal 
control. (By using an intragastric catheter tube (IGC). 
Group II: Diabetic mice received normal saline 14 days by IGC and 
served as diabetic control. 
Group III: Diabetic mice received glibenclamide at the dose of 2mg/ 
Kg body weight, daily, orally for 14 days by IGC. 
Group IV: Diabetic mice received S. caryophyllatum extract at the 
dose of 250 mg/kg b.wt for 14 days by IGC. 
DISCUSSION 
Experimental diabetes mellitus was induced by injecting alloxan, a 
beta cytotoxin induces chemical diabetes (Alloxan diabetes) in a 
wide variety of animal species by damaging the insulin secreting 
pancreatic β-cell, resulting in a decrease in endogenous insulin 
release, which paves way for the decreased utilization of glucose by 
the tissues (Gurusamy et al., 2008). Many workers have shown that 
extracts of S. cumini have shown very good antihyperglycemic 
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activity (Shrotri et al., 1963; Bansal et al., 1981; Achrekar et al., 
1991; Grover et al., 2000; Sharma et al., 2003).  In the present study, 
the effect of the leaf extracts of S. caryophyllatum reflected in body 
weight. The body weight was slightly increased in the normal 
control mice compared to initial body weight, whereas in the 
diabetic control mice there was a significant decrease in the body 
weight. Our results were supported by Esharat (2002), who 
reported that diabetic induced animals showed loss in body weight. 
The hypoglycaemic activity was compared with glibenclamide a 
sulphonylurea, stimulate insulin secretion from pancreatic ß cell 
(Tiedge and Lenzen, 1995). The significant body weight gain after 
treatment with the plant extracts revealed the previous report of E. 
jambolana in diabetic albino rats (Srivastava et al., 2012). The 
hypoglycemic activity of methanolic leaf extract of S. caryophyllatum 
was evaluated in alloxan induced diabetic mice. The results showed 
that fasting plasma glucose (FBG) level remains practically same 
before and after treatment with vehicle (saline only) in case of 
normal control mice. Whereas, in diabetic control mice the fasting 
plasma glucose levels rises significantly in 2 weeks (14 days) after 
treatment with vehicle. Methanolic leaf extracts of S. caryophyllatum 
caused significant (p<0.01) decrease in the fasting glucose in group 
IV. However, diabetic mice treated with glibenclamide a standard 
drug has exhibited maximum reduction in fasting blood sugar when 
compared to normal groups because the standard drug 
glibenclamide stimulate insulin secretion from pancreatic β-cells 
and it may be suggested that the mechanism of action of methanolic 
extracts of S. caryophyllatum was similar to glibenclamide. The 
possible mechanism by which the plant extract decreases the blood 
sugar level may be by potentiation of insulin effect either by 
increasing the pancreatic secretion of insulin from β-cells of islets of 
langerhans or by increasing the peripheral glucose uptake (Aybar et 
al., 2001).  
Glycosylated haemoglobin determinations are self-monitoring of 
blood glucose therefore, it play an important complementary role for 
the management of diabetes mellitus (Thai et al., 1983). In 
uncontrolled or poorly controlled diabetes, there is an increased 
glycosylation of a number of proteins including haemoglobin. 
Glycosylated haemoglobin level is increased in patients with 
diabetes mellitus to approximately 16% and the amount of increase 
was found directly proportional to the fasting blood glucose level. 
During diabetes, the excess glucose present in blood reacts with 
haemoglobin. Therefore, the total haemoglobin level is decreased in 
alloxan diabetic rats (Pari and Amarnath, 2004). Administration of 
the standard drug and methanolic extracts of S. caryophyllatum for 
14 days prevented a significant elevation of glycosylated 
haemoglobin thereby, increasing the level of total haemoglobin in 
diabetic mice. This could be due to the result of improved glycemic 
control produced by the plant extracts. These results were in 
accordance with the studies of Jamshid et al. (2008). 
CONCLUSION 
The present study suggested that the methanolic extract of S. 
caryophyllatum leaves possess a potent hypoglycaemic activity as it 
significantly reduced the fasting blood glucose levels and 
glycosylated haemoglobin levels in alloxan induced mice as 
compared to the diabetic control. And it may be due to the presence 
of secondart metabolites in the extract. 
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